These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30107503)

  • 1. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy.
    Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H
    Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients.
    Chen J; Shao J; Cai R; Shen Y; Zhang R; Liu L; Qi T; Lu H
    PLoS One; 2014; 9(7):e100446. PubMed ID: 24983463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.
    Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW
    J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
    Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D
    Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
    Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
    Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.
    Lee SA; Mefford JA; Huang Y; Witte JS; Martin JN; Haas DW; Mclaren PJ; Mushiroda T; Kubo M; Byakwaga H; Hunt PW; Kroetz DL
    AIDS; 2016 Jul; 30(11):1807-15. PubMed ID: 27088321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
    Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
    Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.
    Boasso A; Vaccari M; Fuchs D; Hardy AW; Tsai WP; Tryniszewska E; Shearer GM; Franchini G
    J Immunol; 2009 Apr; 182(7):4313-20. PubMed ID: 19299731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and Virologic Parameters Associated With Human Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy.
    Blazkova J; Whitehead EJ; Schneck R; Shi V; Justement JS; Rai MA; Kennedy BD; Manning MR; Praiss L; Gittens K; Wender PA; Oguz C; Lack J; Moir S; Chun TW
    J Infect Dis; 2024 Jun; 229(6):1770-1780. PubMed ID: 38128541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
    Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D
    Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.
    Avelino-Silva VI; Miyaji KT; Hunt PW; Huang Y; Simoes M; Lima SB; Freire MS; Caiaffa-Filho HH; Hong MA; Costa DA; Dias JZ; Cerqueira NB; Nishiya AS; Sabino EC; Sartori AM; Kallas EG
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005219. PubMed ID: 27941965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
    Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
    J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.
    Jenabian MA; Costiniuk CT; Mehraj V; Ghazawi FM; Fromentin R; Brousseau J; Brassard P; Bélanger M; Ancuta P; Bendayan R; Chomont N; Routy JP;
    AIDS; 2016 Nov; 30(18):2777-2786. PubMed ID: 27677162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
    Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR
    J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.
    Adu-Gyamfi CG; Snyman T; Hoffmann CJ; Martinson NA; Chaisson RE; George JA; Suchard MS
    Clin Infect Dis; 2017 Oct; 65(8):1356-1358. PubMed ID: 29017244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.
    Jain V; Hartogensis W; Bacchetti P; Hunt PW; Hatano H; Sinclair E; Epling L; Lee TH; Busch MP; McCune JM; Pilcher CD; Hecht FM; Deeks SG
    J Infect Dis; 2013 Oct; 208(8):1202-11. PubMed ID: 23852127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.
    Jenabian MA; Patel M; Kema I; Vyboh K; Kanagaratham C; Radzioch D; Thébault P; Lapointe R; Gilmore N; Ancuta P; Tremblay C; Routy JP
    Clin Exp Immunol; 2014 Oct; 178(1):102-11. PubMed ID: 24924152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study.
    Yue Y; Wang N; Han Y; Zhu T; Xie J; Qiu Z; Song X; Li Y; Routy JP; Wang J; Li T
    BMC Infect Dis; 2017 Dec; 17(1):771. PubMed ID: 29246197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ.
    Ruggiero A; De Spiegelaere W; Cozzi-Lepri A; Kiselinova M; Pollakis G; Beloukas A; Vandekerckhove L; Strain M; Richman D; Phillips A; Geretti AM;
    EBioMedicine; 2015 Sep; 2(9):1153-9. PubMed ID: 26498496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.